Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Sacconi

Showing results (41-50 of 118) with videos related to

Pageof 12
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 1, 2024
DHEA-S, Androstenedione, 17-β-estradiol signature as novel biomarkers for early prediction of risk of malignant pleural mesothelioma linked to asbestos-exposure: A preliminary investigationBarbara Nuvoli, Andrea Sacconi, Grazia Bottillo, et al.
Oncotarget|June 12, 2015
miR-181c associates with tumor relapse of high grade osteosarcomaFederica Mori, Andrea Sacconi, Valeria Canu, et al.
Cancers|August 28, 2020
Loss of Two-Pore Channel 2 (TPC2) Expression Increases the Metastatic Traits of Melanoma Cells by a Mechanism Involving the Hippo Signalling Pathway and Store-Operated Calcium EntryAntonella D'Amore, Ali Ahmed Hanbashi, Silvia Di Agostino, et al.
Plos One|April 8, 2015
Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomasClaudio Pulito, Irene Terrenato, Anna Di Benedetto, et al.
Cell Death & Disease|February 6, 2024
ID4-dependent secretion of VEGFA enhances the invasion capability of breast cancer cells and activates YAP/TAZ via integrin β3-VEGFR2 interactionAnna Benedetti, Chiara Turco, Enzo Gallo, et al.
Oncotarget|December 10, 2017
Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cellsRoberto Dinami, Valentina Buemi, Rosanna Sestito, et al.
Carcinogenesis|November 1, 2016
MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancerFederica Lo Sardo, Mattia Forcato, Andrea Sacconi, et al.
Cancer Biology & Therapy|November 18, 2015
Circulating miR-21-5p and miR-148a-3p as emerging non-invasive biomarkers in thymic epithelial tumorsTeresa Bellissimo, Emanuele Russo, Federica Ganci, et al.
Cancer Letters|March 3, 2022
TRF2 cooperates with CTCF for controlling the oncomiR-193b-3p in colorectal cancerRoberto Dinami, Eleonora Petti, Manuela Porru, et al.
Molecular Oncology|November 7, 2020
The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinomaValentina Panzeri, Isabella Manni, Alessia Capone, et al.
Pageof 12

Showing results (41-50 of 118) with videos related to

Sort By:
Pageof 12
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 1, 2024
DHEA-S, Androstenedione, 17-β-estradiol signature as novel biomarkers for early prediction of risk of malignant pleural mesothelioma linked to asbestos-exposure: A preliminary investigationBarbara Nuvoli, Andrea Sacconi, Grazia Bottillo, et al.
Oncotarget|June 12, 2015
miR-181c associates with tumor relapse of high grade osteosarcomaFederica Mori, Andrea Sacconi, Valeria Canu, et al.
Cancers|August 28, 2020
Loss of Two-Pore Channel 2 (TPC2) Expression Increases the Metastatic Traits of Melanoma Cells by a Mechanism Involving the Hippo Signalling Pathway and Store-Operated Calcium EntryAntonella D'Amore, Ali Ahmed Hanbashi, Silvia Di Agostino, et al.
Plos One|April 8, 2015
Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomasClaudio Pulito, Irene Terrenato, Anna Di Benedetto, et al.
Cell Death & Disease|February 6, 2024
ID4-dependent secretion of VEGFA enhances the invasion capability of breast cancer cells and activates YAP/TAZ via integrin β3-VEGFR2 interactionAnna Benedetti, Chiara Turco, Enzo Gallo, et al.
Oncotarget|December 10, 2017
Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cellsRoberto Dinami, Valentina Buemi, Rosanna Sestito, et al.
Carcinogenesis|November 1, 2016
MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancerFederica Lo Sardo, Mattia Forcato, Andrea Sacconi, et al.
Cancer Biology & Therapy|November 18, 2015
Circulating miR-21-5p and miR-148a-3p as emerging non-invasive biomarkers in thymic epithelial tumorsTeresa Bellissimo, Emanuele Russo, Federica Ganci, et al.
Cancer Letters|March 3, 2022
TRF2 cooperates with CTCF for controlling the oncomiR-193b-3p in colorectal cancerRoberto Dinami, Eleonora Petti, Manuela Porru, et al.
Molecular Oncology|November 7, 2020
The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinomaValentina Panzeri, Isabella Manni, Alessia Capone, et al.
Pageof 12